{"id":"NCT01550003","sponsor":"UCB BIOSCIENCES GmbH","briefTitle":"Pediatric Arthritis Study of Certolizumab Pegol","officialTitle":"A Multicenter, Open-label Study to Assess the Pharmacokinetics, Safety and Efficacy of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Polyarticular-course Juvenile Idiopathic Arthritis (JIA)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-03-08","primaryCompletion":"2024-04-08","completion":"2024-04-08","firstPosted":"2012-03-09","resultsPosted":"2024-10-23","lastUpdate":"2024-10-23"},"enrollment":193,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Polyarticular-course Juvenile Idiopathic Arthritis (JIA)"],"interventions":[{"type":"DRUG","name":"Certolizumab Pegol (CZP)","otherNames":["Cimzia"]},{"type":"DRUG","name":"Certolizumab Pegol (CZP)","otherNames":["Cimzia"]}],"arms":[{"label":"Certolizumab Pegol","type":"EXPERIMENTAL"}],"summary":"A Multicenter, Open-label Study to Assess the Pharmacokinetics, Safety and Efficacy of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Polyarticular-course Juvenile Idiopathic Arthritis (JIA).","primaryOutcome":{"measure":"Certolizumab Pegol (CZP) Plasma Concentration Level at Week 16","timeFrame":"Week 16","effectByArm":[{"arm":"Reduced CZP Dose -Weight Group: 10 - <20 kg","deltaMin":1.6166,"sd":null},{"arm":"Reduced CZP Dose - Weight Group: 20 - <40 kg","deltaMin":9.2277,"sd":null},{"arm":"Reduced CZP Dose - Weight Group: >=40 kg","deltaMin":13.8928,"sd":null},{"arm":"Original CZP Dose - Weight Group: 10 - <20 kg","deltaMin":22.906,"sd":null},{"arm":"Original CZP Dose - Weight Group: 20 - <40 kg","deltaMin":25.7752,"sd":null},{"arm":"Original CZP Dose - Weight Group: >=40 kg","deltaMin":33.568,"sd":null}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":11},"locations":{"siteCount":36,"countries":["United States","Argentina","Brazil","Canada","Chile","Mexico","Russia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":18},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Headache","Juvenile idiopathic arthritis","Pyrexia"]}}